Useless, I don't see anything that addresses the
neuronal cascade of death or any useful rehab strategies. Proves once again there is no strategy to get all stroke survivors 100% recovered.
http://journals.sagepub.com/doi/full/10.1177/2396987317705236
THE NORWEGIAN TENECTEPLASE STROKE TRIAL
(NOR-TEST): RANDOMISED CONTROLLED TRIAL OF TENECTEPLASE VS. ALTEPLASE IN
ACUTE ISCHAEMIC STROKE
EFFICACY OF EARLY COGNITIVE-LINGUISTIC TREATMENT FOR APHASIA DUE TO STROKE; A RANDOMISED CONTROLLED TRIAL (RATS-3)
CLOSURE OF PATENT FORAMEN OVALE, ORAL
ANTICOAGULANTS OR ANTIPLATELET THERAPY TO PREVENT STROKE RECURRENCE
(CLOSE): A RANDOMIZED CLINICAL TRIAL
PROBUCOL FOR PREVENTION OF CARDIOVASCULAR
EVENTS IN ISCHEMIC STROKE PATIENTS WITH HIGH RISK OF CEREBRAL HEMORRHAGE
(PICASSO) STUDY: A MULTICENTER, RANDOMIZED CONTROLLED TRIAL
PROGNOSTIC AND TREATMENT IMPACT OF PENUMBRAL IMAGING IN POOLED ANALYSIS OF RANDOMIZED TRIALS OF ENDOVASCULAR STENT THROMBECTOMY
TESPI(THROMBOLYSIS IN ELDERLY STROKE PATIENTS
IN ITALY): RANDOMIZED CONTROLLED TRIAL OF ALTEPLASE VERSUS STANDARD
TREATMENT IN PATIENTS AGED >80 YEARS WITHIN 3HRS AFTER STROKE ONSET
OFF LABEL USE OF ALTEPLASE FOR ACUTE ISCHEMIC
STROKE (AIS) IN PATIENTS OVER 80 YEARS OF AGE: INDIVIDUAL-PATIENT-DATA
META-ANALYSIS OF EIGHT TRIALS
LOW-DOSE VERSUS STANDARD-DOSE ALTEPLASE BY AGE, ETHNICITY, AND SEVERITY OF ACUTE ISCHAEMIC STROKE: THE ENCHANTED TRIAL
THROMBOLYSIS IMPLEMENTATION IN STROKE (TIPS)
TRIAL: A CLUSTER RANDOMISED CONTROL TRIAL OF IMPLEMENTATION STRATEGIES
FOR INTRAVENOUS THROMBOLYSIS
CHARACTERISTICS, MANAGEMENT AND RESPONSE TO TREATMENT IN CHINESE VS. NON-CHINESE PARTICIPANTS IN THE ENCHANTED TRIAL
THE NORWEGIAN SONOTHROMBOLYSIS IN ACUTE
STROKE STUDY (NOR-SASS). A RANDOMIZED CONTROLLED STUDY OF
CONTRAST-ENHANCED SONOTHROMBOLYSIS
INTRAVENOUS THROMBOLYSIS IN PATIENTS WITH
STROKE UNDER RIVAROXABAN USING DRUG SPECIFIC PLASMA LEVELS – EXPERIENCE
WITH A STANDARD OPERATION PROCEDURE IN CLINICAL PRACTICE
PROFESSIONAL GUIDELINE VERSUS PRODUCT LICENCE
SELECTION FOR TREATMENT WITH IV THROMBOLYSIS: COMPLIANCE WITH PRODUCT
LICENCES IS HIGHEST IN LOWER EFFICIENCY SITES AND RESTRICTS THROMBOLYSIS
USAGE
OUTCOME AFTER ISCHEMIC STROKE IN PATIENTS
OVER 80 YEARS TREATED WITH IV THROMBOLYSIS IN THE 3–4.5H COMPARED TO 3H
TIME WINDOW: RESULTS FROM SITS-ISTR
NON-VITAMIN-K-ANTAGONIST ORAL ANTICOAGULANTS
VERSUS WARFARIN IN PATIENTS WITH ATRIAL FIBRILLATION AND PREVIOUS STROKE
OR TIA: AN UPDATED SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED
CONTROLLED TRIALS
EFFECTIVENESS OF DIRECT ORAL ANTICOAGULANTS IN A POPULATION STUDY OF INCIDENT ATRIAL FIBRILLATION
PREDICTING RISK OF MAJOR BLEEDING IN PATIENTS
WITH ATRIAL FIBRILLATION TREATED WITH ORAL ANTICOAGULATION AFTER TIA OR
STROKE: EXTERNAL VALIDATION OF RISK SCORES
EARLY RECURRENCE AND MAJOR BLEEDING IN
PATIENTS WITH ACUTE ISCHAEMIC STROKE AND ATRIAL FIBRILLATION TREATED
WITH DIRECT ORAL ANTICOAGULANTS. THE RAF-DOAC STUDY
EVALUATING THE EFFECTIVENESS AND SAFETY OF NOVEL ORAL ANTICOAGULANTS COMPARED WITH VITAMIN-K ANTAGONISTS
POPULATION-BASED STUDY OF PROGNOSIS OF BRIEF
EPISODES OF ATRIAL FIBRILLATION ON 5-DAY HOME CARDAIC RHYTHM MONITORING
AFTER TIA AND ISCHAEMIC STROKE
PILOT STUDY OF CARDIAC MAGNETIC RESONANCE IMAGING IN EMBOLIC STROKE OF UNDETERMINED SOURCE (MR-ESUS)
COMPARATIVE EFFECTIVENESS OF NON-VITAMIN K
ANTAGONIST ORAL ANTICOAGULANTS AND WARFARIN IN THE SCOTTISH ATRIAL
FIBRILLATION POPULATION: THE VALUE OF REAL WORLD EVIDENCE
PREDICTIVE FACTORS OF STROKE RECURRENCE IN PATIENTS WITH ISCHEMIC STROKE DUE TO ATRIAL FIBRILLATION
OPTIMAL TIMING TO START RIVAROXABAN
ADMINISTRATION TO PREVENT RECURRENT EMBOLISM IN ACUTE STROKE PATIENTS
WITH NONVALVULAR ATRIAL FIBRILLATION (NVAF): THE RELAXED STUDY
NURSE-LED, TELEPHONE-BASED, SECONDARY
PREVENTIVE FOLLOW-UP AFTER STROKE OR TIA IMPROVES BLOOD PRESSURE AND LDL
CHOLESTEROL: THREE-YEAR RESULTS FROM THE RANDOMIZED CONTROLLED NAILED
STROKE TRIAL
TICAGRELOR VERSUS ASPIRIN IN ACUTE EMBOLIC STROKE OF UNDETERMINED SOURCE (ESUS)
PRIMARY RESULTS OF EBBINGHAUS, A COGNITIVE STUDY OF PATIENTS ENROLLED IN THE FOURIER TRIAL
A CULTURALLY-TAILORED, SKILLS-BASED
INTERVENTION TO REDUCE BLOOD PRESSURE IN A MULTI-ETHNIC GROUP OF
MILD/MODERATE STROKE SURVIVORS WITH HYPERTENSION: RESULTS FROM THE
DESERVE TRIAL
SECULAR TRENDS IN PROCEDURAL STROKE OR DEATH
RISKS OF STENTING VERSUS ENDARTERECTOMY FOR SYMPTOMATIC CAROTID STENOSIS
– A POOLED ANALYSIS OF RANDOMISED TRIALS
RESTENOSIS AFTER STENTING VERSUS
ENDARTERECTOMY FOR SYMPTOMATIC CAROTID STENOSIS AND ITS RELATIONSHIP
WITH RECURRENT STROKE IN THE RANDOMISED INTERNATIONAL CAROTID STENTING
STUDY (ICSS)
ENDOVASCULAR TREATMENT VERSUS ENDARTERECTOMY FOR CAROTID ARTERY STENOSIS: RESULTS FROM THE UPDATED SYSTEMATIC COCHRANE REVIEW
THE EVOLUTION OF CAROTID INTERVENTION:
SECULAR TRENDS IN STENT TYPE, CEREBRAL PROTECTION DEVICES AND MEDICATION
IN ACST-2, A LARGE INTERNATIONAL RCT COMPARING SURGERY WITH STENTING
AN
EPIGENOME WIDE ASSOCIATION STUDY REVEALS AN ALTERED METHYLATION PATTERN
ASSOCIATED WITH ACUTE NEUROLOGICAL OUTCOME AFTER ISCHEMIC STROKE
RARE EXONIC VARIANTS IN EXTREMES OF MRI-MARKERS FOR CEREBRAL SMALL VESSEL DISEASE
TARGETED LIPID PROFILING DISCOVERS NOVEL PLASMA BIOMARKERS OF LARGE VESSEL STROKE: RESULTS OF THE ASPIRE-STROKE STUDY
DILATED PERIVASCULAR SPACES, A MARKER OF CEREBRAL SMALL VESSEL DISEASE, ARE HIGHLY HERITABLE
SERUM AMYLOID A AS AN EARLY PREDICTOR OF STROKE ASSOCIATED INFECTION
GENOME WIDE STUDY FOR RARE VARIANTS REVEALS LOCI ASSOCIATED WITH HEMORRHAGIC TRANSFORMATION AFTER RT-PA
PROTEOMIC SIGNATURE OF TIA/MILD STROKE FROM PERIPHERAL BLOOD SAMPLES DRAWN IN EMERGENCY DEPARTMENTS: THE SPECTRA STUDY
GENOME-WIDE
INTERACTION ANALYSIS WITH HYPERTENSION IN ASSOCIATION WITH WHITE MATTER
HYPERINTENSITY BURDEN: THE COHORTS FOR HEART AND AGING RESEARCH IN
GENOMIC EPIDEMIOLOGY (CHARGE) CONSORTIUM
EXOME SEQUENCING AND CHIP ANALYSES OF SMALL SUBCORTICAL MRI-DEFINED BRAIN INFARCTS
IMPACT
OF WHITE MATTER HYPERINTENSITIES, CEREBRAL MICROBLEEDS AND MEDIAL
TEMPORAL LOBE ATROPHY ON SHORT AND LONG-TERM REHABILITATION OUTCOMES
AFTER STROKE
STEPWISE
RELATIONSHIP BETWEEN SEVERITY OF ACUTE CEREBROVASCULAR EVENTS AND
PRE/POST-EVENT DEMENTIA: POPULATION-BASED STUDY OF TIA AND STROKE
PREDICTORS OF DEMENTIA AFTER TIA/STROKE: 15-YEAR POPULATION-BASED FOLLOW-UP STUDY
TOTAL SMALL VESSEL DISEASE SCORE AND RISK OF RECURRENT STROKE – VALIDATION IN TWO LARGE COHORTS
CEREBRAL MICROBLEEDS AND THE RISK OF INCIDENT ISCHEMIC STROKE IN CADASIL
UP-REGULATION
OF COL4A1 AND COL4A2 GENES THROUGH VARIOUS MECHANISMS LEADS TO SEVERE
EARLY ONSET ISCHAEMIC SMALL VESSEL DISEASE, INCLUDING PADMAL
SPATIAL
RELATION BETWEEN LOBAR MICROBLEEDS AND JUXTACORTICAL PERIVASCULAR
SPACES ON 7T MRI IN AMNESTIC MILD COGNITIVE IMPAIRMENT AND EARLY
ALZHEIMER’S DISEASE
THE DIFFERENTIAL EVOLUTION OF ACUTE SMALL INFARCTS OVER TIME IN PATIENTS WITH SMALL VESSEL DISEASE
PRECISE HISTOLOGICAL-RADIOLOGICAL CORRELATIONS OF BRAIN PATHOLOGY IN SMALL VESSEL DISEASE
EFFECTS
OF STATIN INTENSITY AND ADHERENCE ON THE LONG-TERM PROGNOSIS AFTER
ACUTE ISCHEMIC STROKE: A NATIONWIDE POPULATION-BASED COHORT STUDY
THE PREDICTIVE VALUE OF PULSE PRESSURE DURING ACUTE STAGE OF ISCHEMIC STROKE FOR FUTURE MAJOR VASCULAR EVENTS
SOCIOECONOMIC STATUS AND THE RISK OF STROKE RECURRENCE. PERSISTING GAPS OBSERVED IN A NATIONWIDE SWEDISH STUDY 2001–2012
RISK
OF DEATH, READMISSION, CARDIOVASCULAR AND BLEEDING EVENTS AMONG
PATIENTS WITH AND WITHOUT ATRIAL FIBRILLATION AND MILD, MODERATE AND
SEVERE ISCHEMIC STROKE
EMBOLIC STROKES OF UNDETERMINED SOURCE IN THE HELSINKI YOUNG STROKE REGISTRY: LONG-TERM OUTCOME
EARLY TIME COURSE OF MAJOR AND INTRACRANIAL BLEEDING IN PATIENTS WITH CEREBRAL ISCHAEMIA ON ANTIPLATELET THERAPY
POPULATION-BASED
STUDY OF FREQUENCY, RISK FACTORS AND LONG-TERM PROGNOSIS OF TIA AND
ISCHAEMIC STROKE IN PATIENTS WITH SYMPTOMATIC DISEASE IN OTHER VASCULAR
BEDS
SELF-RATED HEALTH, ONE TO FIVE YEARS AFTER STROKE
PROGNOSTIC SIGNIFICANCE OF BLOOD PRESSURE VARIABILITY ON BEAT-TO-BEAT VERSUS AWAKE AMBULATORY AND DAY-TO-DAY MONITORING
INTRATHECAL
BACLOFEN THERAPY COMPARED TO THE CONVENTIONAL TREATMENT: EFFICACY
RESULTS IN THE MANAGEMENT OF POST-STROKE SPASTICITY OF THE SISTERS
RANDOMIZED CONTROL TRIAL
MODAFINIL IN DEBILITATING FATIGUE AFTER STROKE (MIDAS): A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, CROSS-OVER TRIAL
GENDER DIFFERENCE IN RESPONSE TO FAMILY-LED REHABILITATION AFTER STROKE
EARLY
USE OF ABOBOTULINUMTOXINA IN ADULTS WITH POST-STOKE SPASTICITY IMPROVES
MUSCLE TONE AND INCREASES TIME TO REINJECTION: RESULTS FROM ONTIME AND
ABCDE S STUDIES
NOVEL
NON-INVASIVE DYSPHAGIA DETECTION SYSTEM (DDS) FOR BEDSIDE ASSESSMENT OF
SWALLOWING IN PATIENTS AT RISK OF OROPHARYNGEAL DYSPHAGIA: RESULTS FROM
AN EXPLORATORY STUDY
ANALYSIS
OF MORTALITY AND MORBIDITY AFTER PERCUTANEOUS ENDOSCOPIC
GASTROSTOMY(PEG) AND RADIOLOGICALLY-INSERTED GASTROSTOMY(RIG) – AN EIGHT
–YEAR FOLLOW UP STUDY FROM THE UK
OUTCOME MEASUREMENT IN STROKE UPPER LIMB REHABILITATION TRIALS: DO WE MEASURE WHAT MATTERS?
WHEN NEGLECT IS BEING NEGLECTED: THE POOR SENSITIVITY OF SYMPTOM-BASED ASSESSMENT OF INATTENTION IN ACUTE STROKE
POPULATION-BASED STUDY OF TEMPORAL TRENDS IN INCIDENCE, RISK FACTORS AND AETIOLOGY OF “YOUNG STROKE” IN OXFORDSHIRE, UK
ISCHEMIC STROKE ETIOLOGIC SUBTYPES DISTRIBUTION: A POPULATION-BASED STUDY AND A META-ANALYSIS
TRENDS
IN STROKE SEVERITY AND BASELINE RISK PROFILE IN PATIENTS TREATED ON A
COMPREHENSIVE STROKE UNIT IN NORWAY IN 1994 VERSUS 2012
DILATED PERIVASCULAR SPACES ARE ASSOCIATED WITH HIGH INCIDENT HEMORRHAGIC STROKE RISK
RAPID INCREASE OF THE INCIDENCE OF STROKE IN YOUNG ADULTS IN THE NETHERLANDS BETWEEN 1998 AND 2010
THE MEDIATING ROLE OF THE MICROVASCULATURE ON THE EFFECT OF SMOKING ON ISCHEMIC STROKE: A CAUSAL MEDIATION ANALYSIS
30-YEARS
TREND IN BASELINE CARDIOVASCULAR RISK FACTORS AND OUTCOME FOLLOWING
CAROTID ENDARTERECTOMY WITHIN THREE CONSECUTIVE RANDOMIZED TRIALS
EARLY LIFE RISK FACTORS FOR STROKE IN THE UK BIOBANK
PATENT FORAMEN OVALE IS NOT ASSOCIATED WITH NEW DIFFUSION WEIGHTED IMAGING LESIONS ONE WEEK AFTER AN ISCHEMIC STROKE
CLINICAL
ANALYSIS COMPARING EFFICACY BETWEEN A DISTAL FILTER PROTECTION DEVICE
AND PROXIMAL BALLOON OCCLUSION DEVICE DURING CAROTID ARTERY STENTING
OUTCOMES
FROM MECHANICAL THROMBECTOMY IN THE UNITED KINGDOM: COMPARISON OF SAFE
IMPLEMENTATION OF THROMBOLYSIS IN STROKE-THROMBECTOMY REGISTRY
(SITS-TBY) WITH HERMES META-ANALYSIS ENDOVASCULAR TRIALS DATA
INTRACRANIAL
ATHEROSCLEROTIC OCCLUSION ON ENDOVASCULAR REVASCULARIZATION THERAPY:
ANALYSIS OF ACUTE STROKE DUE TO INTRACRANIAL ATHEROSCLEROTIC OCCLUSION
AND NEUROINTERVENTION – KOREAN RETROSPECTIVE REGISTRY
NATIONAL RESULTS OF ENDOVASCULAR TREATMENT OF ACUTE ISCHEMIC STROKE 2011–2015, DENMARK
OUTCOME AND SAFETY OF ENDOVASCULAR TREATMENT IN DENMARK 2011–2015 APPLYING KEY INCLUSION CRITERIA FROM THE MR-CLEAN STUDY
RISK
FACTORS FOR SYMPTOMATIC INTRACRANIAL HEMORRHAGE AFTER ENDOVASCULAR
THERAPY IN ACUTE STROKE WITH LARGE VESSEL OCCLUSION IN THE ANTERIOR
CIRCULATION
ACUTE ENDOVASCULAR TREATMENT OF CAROTID TANDEM LESIONS: STENTING OR NOT STENTING, THE NEVER ENDING STORY
OUT OF BOUNDS: ENDOVASCULAR TREATMENT OF STROKE BEYOND GUIDELINES IN A SINGLE CENTER EXPERIENCE
MECHANICAL THROMBECTOMY FOR STROKE IN THE ELDERLY
OUTCOME
ANALYSIS FOR ANTIHYPERTENSIVE TREATMENT FOR ACUTE CEREBRAL HEMORRHAGE
(ATACH) II TRIAL USING REPEATED SYSTOLIC BLOOD PRESSURE MEASURES
EFFICIENCY
OF INTRAVENTRICULAR HEMORRHAGE REMOVAL IN THE CLOT LYSIS: EVALUATION OF
ACCELERATED RESOLUTION OF INTRAVENTRICULAR HEMORRHAGE TRIAL (CLEAR III)
INTRAVENTRICULAR
HEMORRHAGE: WHO DIES AND WHY: MORTALITY REVIEW FOR THE CLOT LYSIS:
EVALUATION OF ACCELERATED RESOLUTION OF INTRAVENTRICULAR HEMORRHAGE
TRIAL (CLEAR III)
PREDICTORS OF NEUROLOGICAL DETERIORATION IN INTRACEREBRAL HAEMORRHAGE: RESULTS OF INTERIM DATA FROM THE TICH-2 TRIAL
TARGETING EXPANSION IN INTRACEREBRAL HEMORRHAGE: INTENSIVE BLOOD PRESSURE REDUCTION AND NON-CONTRAST CT MARKERS
VERY EARLY HEMATOMA EXPANSION LIMITS EFFICACY OF HEMOSTATIC THERAPY IN THE SPOTLIGHT RANDOMIZED CONTROLLED TRIAL
WHITE
MATTER LESIONS INFLUENCE ON INTRACEREBRAL HEMORRHAGE EXPANSION AND
FUNCTIONAL OUTCOME: A SECONDARY ANALYSIS OF MISTIE-II AND CLEAR-III
INTENSIVE
BLOOD PRESSURE LOWERING DOES NOT INCREASE RISK OF DIFFUSION WEIGHTED
IMAGING HYPERINTENSE LESIONS IN INTRACEREBRAL HEMORRHAGE
AGGRESSIVE
BLOOD PRESSURE REDUCTION IN ACUTE INTRACEREBRAL HEMORRHAGE INCREASES
ACUTE CEREBRAL ISCHEMIA WITH CLINICAL DETERIORATION
NEUTROPHIL EXTRACELLULAR TRAPS IN THROMBI FROM PATIENTS WITH ACUTE ISCHEMIC STROKE
IMAGING-GUIDED
ADVANCES IN A MOUSE MODEL OF RADIOLOGICALLY SILENT TRANSIENT ISCHAEMIC
ATTACK: ULTRA-SENSITIVE MOLECULAR MRI AND CONTRAST-ENHANCED MRI DISCLOSE
ENDOTHELIAL DYSFUNCTIONS AND ALTERED FLUID DRAINAGE
NOVEL THERANOSTIC PROTOCELLS FOR INTRACEREBRAL HEMORRHAGE
THROMBUS
NEUTROPHIL EXTRACELLULAR TRAPS BURDEN IN THROMBI RETRIEVED DURING
ENDOVASCULAR THERAPY ARE RESPONSIBLE FOR T-PA INDUCED THROMBOLYSIS
RESISTANCE
NEURONAL PROTHROMBIN MEDIATES ASTROCYTE ACTIVATED EARLY PROTECTIVE RESPONSE VIA PROTEASE-ACTIVATED RECEPTORS (PAR-1) IN ISCHEMIA
MATRIX
METALLOPROTEINASES AND THEIR TISSUE INHIBITORS ARE ALTERED IN
CERVICOCEREBRAL ARTERY DISSECTION – RESULTS OF A PROSPECTIVE MULTICENTER
STUDY ON INFLAMMATORY BIOMARKERS
REDUCED PLASMA LEVELS OF NEURAL CELL ADHESION MOLECULE ARE ASSOCIATED WITH EARLY SEIZURES IN STROKE PATIENTS
LYMPHOCYTES PREVENT HEMORRHAGIC TRANSFORMATION IN SEVERE ISCHEMIC STROKE
HEADS AND TAILS OF NATRIURETIC PEPTIDES: NEUROPROTECTIVE ROLE OF BRAIN NATRIURETIC
PARIETAL
OPERCULUM AND MOTOR CORTEX ACTIVITIES PREDICT MOTOR RECOVERY IN
MODERATE TO SEVERE STROKE (ON BEHALF OF ISIS-HERMES STUDY GROUP)METABOLOMIC PROFILING IN CADASIL
NON-TARGETED
SERUM METABOLOMICS AFTER HUMAN ISCHEMIC STROKE IDENTIFIES ACUTELY
ELEVATED 2-AMINOBUTYRIC ACID AND PREGNENOLONE SULFATE
INTERNAL
CAROTID ARTERY DISSECTION IS ASSOCIATED WITH LONGER STYLOID PROCESS AND
SHORTER STYLOID PROCESS – INTERNAL CAROTID ARTERY DISTANCE
PLAQUE INFLAMMATION IMAGING IS USEFUL IN PREDICTING RECURRENT CEREBRAL ISCHEMIA IN CAROTID STENOSIS
INCREASED
PLATELET ACTIVATION IN MICRO-EMBOLI NEGATIVE RECENTLY SYMPTOMATIC
VERSUS ASYMPTOMATIC CAROTID STENOSIS: RESULTS FROM THE HAEMOSTASIS IN
CAROTID STENOSIS (HEIST) STUDY
JUXTALUMINAL ECHODENSITY AS AN INDEX OF CAROTID PLAQUE BEHAVIOUR
NEUROFILAMENT LIGHT CHAIN AS A SERUM MARKER FOR CEREBRAL SMALL VESSEL DISEASE
IMPAIRMENT
OF CEREBROVASCULAR REACTIVITY IS ASSOCIATED WITH INCREASED WHITE MATTER
HYPERINTENSITY AND PERIVASCULAR SPACE BURDENS IN PATIENTS WITH
ISCHAEMIC STROKE PRESENTATIONS OF SMALL VESSEL DISEASE
DIAGNOSTIC CRITERIA FOR TRANSIENT ISCHAEMIC ATTACKS (TIA) VERSUS LONG-TERM PROGNOSIS: A POPULATION-BASED STUDY
LOWER DEMENTIA RISK WITH DIFFERENT CLASSES OF ANTIHYPERTENSIVE MEDICATION IN OLDER PATIENTS
AGE-SPECIFIC
RISKS, SEVERITY, TIME-COURSE AND OUTCOME OF BLEEDING ON LONG-TERM
ANTIPLATELET TREATMENT AFTER VASCULAR EVENTS: POPULATION-BASED STUDY
POPULATION-BASED STUDY OF PROGNOSTIC VALUE AND CONTROL OF NOCTURNAL BP AFTER TIA AND STROKE
THE DIAGNOSIS OF UNCERTAIN ORIGIN BENIGN TRANSIENT EVENTS (DOUBT) STUDY
THE ASSOCIATION OF ADULT VACCINATION AND THE RISK OF ISCHEMIC STROKE: A SYSTEMATIC REVIEW AND META-ANALYSIS
ANTIPLATELET REGIMEN FOR PATIENTS WITH BREAKTHROUGH STROKES WHILE ON ASPIRIN: A SYSTEMATIC REVIEW AND META-ANALYSIS
ARTERIAL STIFFNESS IS ASSOCIATED WITH BASAL GANGLIA ENLARGED PERIVASCULAR SPACES AND CEREBRAL SMALL VESSEL DISEASE LOAD
DRIP ‘N SHIP VERSUS DIRECT TO THROMBECTOMY CENTRE: CONDITIONAL PROBABILITY MODELLING IN IRELAND
MORTALITY
AND DISABILITY ACCORDING TO BASELINE BLOOD PRESSURE IN ACUTE ISCHEMIC
STROKE PATIENTS ELIGIBLE FOR THROMBECTOMY: A COLLABORATIVE POOLED
ANALYSIS
ESO ESMINT EAN SAFE SURVEY ON ACUTE ENDOVASCULAR STROKE CARE IN EUROPE
ONE STOP MANAGEMENT OF ACUTE STROKE PATIENTS: MINIMIZING DOOR TO REPERFUSION TIMES
TIME
TO TREATMENT AND FUNCTIONAL OTUCOME AFTER INTRA-ARTERIAL TREATMENT IN
CLINICAL PRACTICE – RESULTS FROM THE MR CLEAN REGISTRY
TRANSFER-RELATED DELAY AND FUNCTIONAL OUTCOME AFTER INTRA-ARTERIAL TREATMENT; RESULTS FROM THE MR CLEAN REGISTRY
SAFETY
AND FUNCTIONAL OUTCOME AFTER INTRA-ARTERIAL TREATMENT FOR ACUTE
ISCHEMIC STROKE WITHOUT PRIOR INTRAVENOUS THROMBOLYSIS IN CLINICAL
PRACTICE: RESULTS FROM THE MR CLEAN REGISTRY
THE IMPACT OF NATIONWIDE CENTRALLY ORGANIZED STROKE CARE SYSTEM ON RECANALIZATION RATES: CZECH REPUBLIC EXPERIENCE
VASCULAR AND CLINICAL OUTCOME IN ACUTE SYMPTOMATIC EXTRACRANIAL INTERNAL CAROTID ARTERY OCCLUSION
IMPACT OF CLINICAL TRIAL PARTICIPATION ON ‘DOOR-TO-NEEDLE’ TIME PERFORMANCE: THE ENCHANTED TRIAL
12 month outcomes from A Very Early Rehabilitation Trial (AVERT)
INTENSIVE
VERSUS GUIDELINE ANTIPLATELET THERAPY IN PATIENTS WITH MINOR ISCHAEMIC
STROKE: DATA FROM THE TRIPLE ANTIPLATELETS FOR REDUCING DEPENDENCY IN
ISCHAEMIC STROKE (TARDIS) TRIAL
HYPOTHERMIA IN ADDITION TO DECOMPRESSIVE HEMICRANIECTOMY AFTER MALIGNANT INFARCTION
SPECIFIC
POINT-OF-CARE TESTING OF COAGULATION IN PATIENTS TREATED WITH
NON-VITAMIN K ANTAGONIST ORAL ANTICOAGULANTS PART I (SPOCT-NOAC I)
ANTIBIOTIC PROPHYLAXIS IN ACUTE ISCHEMIC AND HEMORRHAGIC STROKE PATIENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS
DIAGNOSTIC VALUE OF NEW SEMIQUANTITATIVE IMAGING MARKERS OF CEREBRAL VENOUS THROMBOSIS: A MULTICENTER STUDY
TEMPORAL TRENDS IN STROKE MORTALITY RATES FROM 1987 TO 2012 ACCORDING TO SEX. THE DIJON STROKE REGISTRY
MARRIAGE, DIVORCE, SINGLE LIVING, WIDOWHOOD AND THE RISK FOR STROKE. A DANISH NATION-WIDE POPULATION-BASED STUDY
AGE- AND SEX-SPECIFIC ANALYSIS OF CHARACTERISTICS AND OUTCOMES OF PATIENTS WITH EMBOLIC STROKE OF UNDETERMINED SOURCE
TRAJECTORIES OF DEPRESSION SYMPTOMS LONG TERM AFTER STROKE IN MEN AND WOMEN: THE SOUTH LONDON STROKE REGISTER
TRENDS IN ISCHEMIC STROKE RATES BY SEX FROM 2000 TO 2013: RESULTS FROM THE BRAIN ATTACK SURVEILLANCE IN CORPUS CHRISTI PROJECT
SEX DIFFERENCES IN RESPONSE TO THROMBOLYSIS IN ACUTE ISCHEMIC STROKE: ENCHANTED RESULTS
POORER QUALITY OF LIFE AT 3–6 MONTHS AFTER STROKE IN WOMEN COMPARED TO MEN IS DUE TO AGE AND SEVERITY BUT NOT CLINICAL CARE
SEX DIFFERENCES IN STROKE OUTCOMES: ANALYSIS FROM THE SOUTH LONDON STROKE REGISTER
PUERPERIUM BUT NOT PREGNANCY IS A RISK FACTOR FOR CEREBRAL VENOUS THROMBOSIS
LOW FETAL HEMOGLOBIN PERCENTAGE IS ASSOCIATED WITH SILENT WHITE MATTER CHANGES IN ADULTS WITH HOMOZYGOUS SICKLE CELL DISEASE
SCREENING FOR MONOGENIC CEREBRAL SMALL VESSEL DISEASE USING WHOLE GENOME SEQUENCING
ADDITIONAL CORTICOSTEROID TREATMENT IMPROVES OUTCOME IN CHILDHOOD STROKE DUE TO TRANSIENT FOCAL ARTERIOPATHY
PREVALENCE AND TEMPORAL EVOLUTION OF COGNITIVE DYSFUNCTION IN YOUNG STROKE – FIRST DATA FROM A PROSPECTIVE SINGLE-CENTRE STUDY
FEASIBILITY AND SAFETY OF THROMBOLYSIS AND THROMBECTOMY IN CHILDREN WITH ACUTE ISCHAEMIC STROKE
SUBOPTIMAL USE OF SECONDARY PREVENTION AFTER STROKE IN YOUNG ADULTS: THE FUTURE STUDY
RARE RNF213 VARIANTS LOCATED IN THE C-TERM REGION ENCOMPASSING THE RING DOMAIN ARE ASSOCIATED WITH MOYAMOYA IN CAUCASIANS
AFTER
30-YEARS INCREASING INCIDENCE OF HOSPITALIZATION FOR STROKE IN YOUNG
ADULTS INCIDENCE IS NOW DECREASING. A NATION-WIDE POPULATION-BASED STUDY
OF STROKE IN DANISH HOSPITALS 1980–2014
UTILITY OF CURRENT THROMBOPHILIA SCREENING IN YOUNG STROKE AND TIA PATIENTS
SEROTONIN
REUPTAKE INHIBITORS AND RISK OF SYMPTOMATIC INTRACEREBRAL HEMORRHAGE
FOLLOWING THROMBOLYSIS – FINDINGS FROM THE TRISP COLLABORATION
INTRAVENOUS THROMBOLYSIS FOR PATIENTS WITH IN-HOSPITAL STROKE ONSET: PROPENSITY-MATCHED ANALYSIS FROM THE SITS-EAST REGISTRY
REDUCING DOOR-TO-NEEDLE TIMES AT 17 HOSPITALS TO 36 MINUTES
EXPLANATIONS OF LATE ADMISSION OUTSIDE THE THERAPEUTIC TIME WINDOW IN ACUTE ISCHEMIC STROKE: INTERVIEW OF 1114 STROKE PATIENTS
FIVE-YEAR SURVIVAL AFTER THROMBOLYSIS: A PROPENSITY SCORE MATCHED STUDY USING THE SOUTH LONDON STROKE REGISTER
LOW THROMBIN GENERATION PREDICTS POOR PROGNOSIS IN ISCHEMIC STROKE PATIENTS AFTER THROMBOLYSIS
IMPACT
OF STROKE CODE: AN ATTEMPT TO IMPROVE INTRAVENOUS THROMBOLYSIS RATE
& SHORTEN DOOR TO NEEDLE TIME IN ACUTE ISCHEMIC STROKE
INFLUENCE
OF DEMOGRAPHIC AND CLINICAL CHARACTERISTICS ON TPA-USE OVER TIME: A
MULTIVARIATE ANALYSIS OF PATIENT-DATA IN THE AUSTRIAN STROKE-UNIT
REGISTRY
THE
ROLE OF PRO- AND ANTI-INFLAMMATORY CYTOKINES IN ISCHEMIC STROKE
PATIENTS TREATED WITH TPA THROMBOLYSIS: RESULTS FROM THE MAGIC STUDY
ATRIAL
FIBRILLATION IN TIA AND ISCHEMIC STROKE PATIENTS WITH A PRIOR STROKE IN
COMPARISON TO THOSE WITHOUT. A SWEDISH STROKE REGISTER (RIKSSTROKE)
STUDY
WHITE MATTER HYPERINTENSITY MORPHOMETRY PROVIDES NOVEL INFORMATION ABOUT FUTURE RISK OF STROKE
GAMMA-GLUTAMYL TRANSFERASE PREDICTS STROKE RISK INDEPENDENT OF ALCOHOL CONSUMPTION: A KOREAN NATIONAL SAMPLE COHORT STUDY
EMBOLIC STROKES OF UNDETERMINED SOURCE IN THE HELSINKI YOUNG STROKE REGISTRY: BASELINE CHARACTERISTICS
AMBULATORY
BLOOD PRESSURE LEVELS RELATE TO WHITE MATTER HYPERINTENSITIES
PROGRESSION IN PRIMARY HIPERTENSIVES. RESULTS FROM THE ISSYS
(INVESTIGATING SILENT STROKES IN HYPERTENSIVES: A MRI STUDY)
CEREBRAL
ARTERIAL PULSATILITY IS ASSOCIATED WITH LEUKOARAIOSIS AND RECURRENT
CEREBROVASCULAR EVENTS INDEPENDENTLY OF AGE AND BLOOD PRESSURE
BASELINE COGNITIVE SCORE AT TIME OF FIRST TIA/STROKE PREDICTS RISK AND SEVERITY OF RECURRENT STROKE: POPULATION-BASED STUDY
7 YEAR TRENDS IN SUBDURAL HAEMORRHAGE: INCIDENCE AND ASSOCIATION WITH ANTICOAGULATION USAGE
RUPTURE RISK FOR FAMILIAL COMPARED TO SPORADIC INTRACRANIAL ANEURYSMS
IMPACT
OF TRANSCRANIAL DOPPLER ULTRASOUND ON LOGISTICS AND OUTCOMES IN
PATIENTS TREATED WITH INTRAVENOUS THROMBOLYSIS FOR ACUTE ISCHEMIC
STROKE. RESULTS FROM THE SITS-ISTR
PREHOSPITAL STROKE SCALE (FAST PLUS TEST) PREDICTS PATIENTS WITH LARGE ARTERIAL VESSEL INTRACRANIAL OCCLUSION
WHICH HOSPITAL-LEVEL ORGANISATIONAL FACTORS CONTRIBUTE TO THE VARIATION IN MORTALITY FOR STROKE PATIENTS?
BETWEEN
AND WITHIN CENTER EFFECTS OF VOLUME ON WORKFLOW AND OUTCOME IN
INTRA-ARTERIAL TREATMENT FOR ACUTE ISCHEMIC STROKE: RESULTS FROM THE MR
CLEAN REGISTRY
VARIATION IN THE USE OF URINARY CATHETERS IN ACUTE STROKE: EXPLORATION OF HEAD POSITION IN STROKE TRIAL (HEADPOST) TRIAL DATA
COST-EFFECTIVENESS OF ENDOVASCULAR THERAPY USING MECHANICAL THROMBECTOMY DEVICES FOR ACUTE ISCHAEMIC STROKE
VARIATION
IN THE MANAGEMENT OF VENOUS THROMBOEMBOLISM (DVT AND PE) ACROSS THE
WORLD: EXPLORATION OF HEAD POSITION IN STROKE TRIAL (HEADPOST) TRIAL
DATA
VARIATION
IN THE IDENTIFICATION AND MANAGEMENT OF DYSPHAGIA AND PNEUMONIA ACROSS
THE WORLD: EXPLORATION OF HEAD POSITION IN STROKE TRIAL (HEADPOST) TRIAL
DATA
HOW USEFUL IS SIMULATION TRAINING
MECHANICAL
THROMBECTOMY FOR MINOR AND MILD STROKE PATIENTS HARBORING LARGE VESSEL
OCCLUSION IN THE ANTERIOR CIRCULATION: A MULTICENTER CASE CONTROL STUDY
A
NON-INFERIORITY, RANDOMIZED TRIAL OF THE SAFETY AND EFFECTIVENESS OF
THE PENUMBRA 3D REVASCULARIZATION DEVICE AS AN ADJUNCT TO ASPIRATION IN
ACUTE ISCHEMIC STROKE
ECONOMIC
EVALUATION ALONGSIDE THE MULTICENTER RANDOMIZED CLINICAL TRIAL OF
ENDOVASCULAR TREATMENT FOR ACUTE ISCHEMIC STROKE IN THE NETHERLANDS – MR
CLEAN TRIAL
STRATIS REGISTRY: USE OF GENERAL ANESTHESIA AND IMPACT ON CLINICAL OUTCOME
MECHANICAL THROMBECTOMY IN PATIENTS WITH ACUTE ISCHEMIC STROKE ON ANTICOAGULATION THERAPY
SAFETY AND OUTCOME OF INTRA-ARTERIAL TREATMENT FOR MINOR ISCHEMIC STROKE: RESULTS OF MR CLEAN REGISTRY
ASSOCIATION
OF COLLATERAL STATUS ON BASELINE CTA WITH CLINICAL OUTCOME IN ACUTE
ISCHEMIC STROKE; RESULTS FROM THE MR CLEAN REGISTRY
COMPARISON OF RADIOLOGICAL OUTCOMES IN PATIENTS WITH ACUTE ISCHEMIC STROKE TREATED WITH DIFFERENT THROMBECTOMY TECHNIQUES
CLINICAL
OUTCOME OF ACUTE ISCHEMIC STROKE PATIENTS WITH EMERGENT ARTERIAL TANDEM
OCCLUSIONS BY CERVICAL CAROTID TYPE OF REVASCULARIZATION
PREDICTORS FOR GOOD COLLATERALS IN 857 PATIENTS WITH ACUTE ISCHEMIC STROKE AND PROXIMAL MIDDLE CEREBRAL ARTERY OCCLUSION
THE CORE OF INFARCTION IN CT PERFUSION: RELIABLE ESTIMATOR OF REAL INFARCTION?
VALIDATING A PREDICTIVE MODEL OF ACUTE ADVANCED IMAGING BIOMARKERS IN ISCHEMIC STROKE
EXTENDING
THE TIME FOR THOMBOLYSIS IN EMERGENCY NEUROLOGICAL DEFICITS (EXTEND) –
PENUMBRAL CHARACTERISTICS AMONG PATIENTS 4.5-9 HRS AND WAKE – UP STROKE
REVISING COLLATERAL SCORING ON SINGLE-PHASE CTA: INSIGHTS GAIN FROM MULTI-PHASE CTA
QUANTITATIVE
ASSESSMENT OF PLAQUE ENHANCEMENT IN SYMPTOMATIC INTRACRANIAL
ATHEROSCLEROTIC LESIONS: A HIGH RESOLUTION MAGNETIC RESONANCE IMAGING
STUDY
CLINICAL
CORRELATES, PROGNOSTIC IMPLICATIONS AND ETHNIC DIFFERENCES OF
PERIVASCULAR SPACES IN PATIENTS WITH TIA AND ISCHAEMIC STROKE
A
CLINICAL PREDICTION RULE WOULD ALLOW MORE EFFECTIVE CTA UTILIZATION OF
VASCULAR IMAGING FOR SUSPECTED MILD ACUTE CEREBROVASCULAR (ACVS) IN THE
EMERGENCY DEPARTMENT
IS INFARCT VOLUME ON CT A USEFUL PROXY FOR FUNCTIONAL OUTCOME? RESULTS FROM THE MR CLEAN TRIAL
CORTICAL SUPERFICIAL SIDEROSIS IN DIFFERENT TYPES OF CEREBRAL SMALL VESSEL DISEASE
ACUTE ISCHEMIC LESIONS ARE ASSOCIATED WITH CORTICAL SUPERFICIAL SIDEROSIS IN SPONTANEOUS INTRACEREBRAL HEMORRHAGE
LACK OF EARLY IMPROVEMENT PREDICTS POOR CLINICAL OUTCOME FOLLOWING ACUTE INTRACEREBRAL HEMORRHAGE
ASSOCIATIONS WITH HAEMORRHAGIC TRANSFORMATION IN ACUTE ISCHEMIC STROKE
PREDICTING
PRESENCE OF MACROVASCULAR CAUSES IN PATIENTS WITH NON-TRAUMATIC
INTRACEREBRAL HAEMORRHAGE BASED ON PATIENT AND HAEMORRHAGE
CHARACTERISTICS; THE DIAGRAM PREDICTION SCORE
SMASH-U
VERSUS H-ATOMIC: A RANDOMIZED HEAD-TO-HEAD COMPARISON FOR THE ETIOLOGIC
CLASSIFICATION OF PATIENTS WITH INTRACEREBRAL HEMORRHAGE
IMPLEMENTATION
OF AN ACUTE CARE BUNDLE FOR INTRACEREBRAL HAEMORRHAGE: EXPERIENCE AT A
UK COMPREHENSIVE STROKE CENTRE AND ASSOCIATED REDUCTION IN 30-DAY CASE
FATALITY
BETTER
FUNCTIONAL OUTCOME AND LOWER RISK OF MORTALITY FOR PATIENTS WITH
INTRACRANIAL HEMORRHAGE ON STROKE UNITS COMPARED TO INTENSIVE CARE UNITS
AND NORMAL WARDS
ABSOLUTE
RISK AND PREDICTORS OF THE GROWTH OF ACUTE SPONTANEOUS PRIMARY
INTRACEREBRAL HAEMORRHAGE: AN INDIVIDUAL PATIENT DATA META-ANALYSIS
LONG-TERM
PREDICTORS OF MORTALITY AND FUNCTIONAL OUTCOME AFTER DECOMPRESSIVE
HEMICRANIECTOMY FOR MALIGNANT MIDDLE CEREBRAL ARTERY INFARCTION
TIME-COURSE
OF EVOLUTION OF FUNCTIONAL RECOVERY AND CAUSE-SPECIFIC MORTALITY AFTER
ISCHAEMIC STROKE: IMPLICATIONS FOR TRIAL DESIGN AND INTERPRETATION
DERIVATION AND VALIDATION OF A NOVEL, PARSIMONIOUS, BIOMARKER-BASED PROGNOSTIC SCORE IN ISCHEMIC STROKE: THE CORISK-SCORE
PERFORMANCE
OF THE ORDINAL VERSUS DICHOTOMIZED MODIFIED RANKIN SCALE IN PREDICTING
5-YEAR DEATH, DISABILITY, AND HEALTHCARE COSTS AFTER ISCHAEMIC STROKE:
IMPLICATIONS FOR CLINICAL TRIALS
IMPACT OF ANTI-N-METHYL-D-ASPARTATE-RECEPTOR (NMDAR) NR1 ANTIBODIES ON LONG-TERM FUNCTIONAL OUTCOME IN STROKE PATIENTS
IMPACT OF STROKE ASSOCIATED PNEUMONIA ON MORTALITY, LENGTH OF HOSPITAL STAY AND FUNCTIONAL OUTCOME FOLLOWING ACUTE STROKE
OUTCOME AFTER POSTERIOR CIRCULATION STROKE – PROPENSITY SCORE MATCHING ANALYSIS FROM THE AUSTRIAN STROKE UNIT REGISTRY
COMPARISON
OF LONG-TERM SPONTANEOUS FUNCTIONAL RECOVERY AND RESPONSE TO TREATMENT
WITH MLC601 BETWEEN CORTICAL AND NON-CORTICAL STROKES – THE CHIMES-E
STUDY
REDUCTION IN MORTALITY AFTER STROKE IN YOUNG ADULTS IN THE NETHERLANDS
No comments:
Post a Comment